To date, it is well established that neurological and neuropsychic disorders persist for a long time in a significant part of adult patients who have undergone COVID-19, despite the fact that there is much less information about the manifestations of postcovid syndrome (PCS) in children and adolescents. The review provides data on the features of the course of PCS in young patients, discusses the possibilities of treating such patients. The results of studies on the use of the drug Cortexin for the correction of cognitive and emotional disorders are analyzed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/jnevro202212204123 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!